SS Innovations International, Inc. (NASDAQ: SSII) announced the successful completion of what it says is the world’s longest-distance robotic telesurgery. The company performed a robot-assisted cardiac procedure across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India using the SSi Mantra surgical robotic system. The procedure was conducted remotely by CEO and cardiac surgeon Dr. Sudhir Srivastava from Guyana, while the patient-side robotic system operated in India, functioning with network latency of approximately 290-300 milliseconds.
The achievement surpasses the company’s previous telesurgery distance record of approximately 6,250 miles and further demonstrates the capabilities of the SSi Mantra platform in long-distance surgical applications. This milestone coincided with the launch of Guyana’s National Robotic Surgery Program and follows regulatory approval for the SSi Mantra in Guyana. According to the company, 173 telesurgeries have now been performed using the platform globally, including 22 cardiac telesurgeries, making SSi Mantra the only surgical robotic system currently used for robotic cardiac telesurgery.
The implications of this record are significant for global healthcare. By enabling surgeons to operate on patients thousands of miles away, the technology could bridge gaps in access to specialized surgical care, particularly in underserved regions. For instance, patients in remote areas of Guyana or other developing nations could receive advanced cardiac procedures without needing to travel abroad. The low latency of 290-300 milliseconds is crucial for ensuring precision and safety in such delicate operations, and the successful completion of this procedure suggests that distance is no longer a barrier for robotic telesurgery.
For the industry, this achievement positions SS Innovations as a leader in telesurgery, potentially accelerating adoption of robotic systems in regions with limited surgical expertise. The company’s focus on making robotic surgery affordable and accessible aligns with global health equity goals. Dr. Srivastava’s ability to perform the surgery from Guyana to India highlights the scalability of the technology, which could be replicated in other parts of the world. The launch of Guyana’s National Robotic Surgery Program further underscores the growing acceptance of these innovations.
SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra surgical robotic system and its SSi Mudra surgical instruments. For more information, visit the company’s website at https://ssinnovations.com/.
